BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, G...
FDA Recall #D-0086-2026 — Class II — July 30, 2025
Product Description
BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).
Reason for Recall
Lack of Assurance of Sterility
Recalling Firm
GenoGenix LLC — Boca Raton, FL
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Distribution
US Nationwide.
Code Information
Lot#: GG020525-001, GG060525-001, GG062625-004, within expiry.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated